A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
NYS Entity Status
NYS Filing Date
JULY 12, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - GMP ESTIMATING & CONSULTING, INC.
AROUND THE WEB
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
- AT&T tops Wall Street's profit, revenue forecasts
Tuesday Jul 25, 2017
DALLAS (AP) — Shares of AT&T Inc. rose Tuesday after the company's second-quarter profit and revenue beat industry analysts' projections.AT&T bought DirecTV in 2015 and wants the owner of the CNN, TBS and HBO networks and a movie studio so that it can expand beyond its traditional business lines as the wireless phone industry becomes more competitive.AT&T said Tuesday that it added 127,000 wireless customers — users of cellphones and tablets — who pay a bill at the end of the month, the more lucrative kind of customer.Earnings, adjusted for one-time gains and costs, were 79 cents per share, beating the 74-cent estimate of the 20 analysts surveyed by Zacks Investment Research.
- The CMO's Role When Choosing Ad, Marketing Tech
Monday May 15, 2017
Forrester analysts estimate 37% of all new tech project spending will be related to the CMO, including marketing automation software, marketing data analytics, mobile apps, and related consulting andstaff spending.
- Snap stock is tanking again after user growth slows down
By Christopher Zara - Thursday Aug 10, 2017
This is not good news for Snap Inc. The parent company of Snapchat saw its shares tumble in after-hours trading today after it reported disappointing user growth in its Q2 2017 earnings. It’s only the second earnings report since Snap went public in March, and hopes for a turnaround are deteriorating. Shares fell to $11.90 after … Continue reading “Snap stock is tanking again after user growth slows down”
This is not good news for Snap Inc. The parent company of Snapchat saw its shares tumble in after-hours trading today after it reported disappointing user growth in its Q2 2017 earnings. It’s only the second earnings report since Snap went public in March, and hopes for a turnaround are deteriorating. Shares fell to $11.90 after hours, an all-time low. Snap debuted on the NYSE at $17 a share. It fell below that price a month ago and hasn’t recovered. The company reported daily active users growth of 7 million to 173 million total, but analysts were expecting about 8 million new users, CNBC reports. You can check out Snap’s full earnings release here. We’ll have more after the call later today.